Racanelli, Vito
 Distribuzione geografica
Continente #
NA - Nord America 4.218
AS - Asia 3.748
EU - Europa 2.310
SA - Sud America 954
AF - Africa 92
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.332
Nazione #
US - Stati Uniti d'America 4.067
SG - Singapore 1.443
IT - Italia 829
BR - Brasile 779
VN - Vietnam 734
CN - Cina 686
RU - Federazione Russa 327
DE - Germania 323
KR - Corea 216
FR - Francia 172
LV - Lettonia 147
BD - Bangladesh 146
FI - Finlandia 112
HK - Hong Kong 109
IN - India 102
ID - Indonesia 93
NL - Olanda 93
GB - Regno Unito 91
CA - Canada 75
AR - Argentina 70
MX - Messico 45
IQ - Iraq 43
PL - Polonia 37
EC - Ecuador 32
AT - Austria 31
SE - Svezia 31
ES - Italia 30
CO - Colombia 23
PK - Pakistan 23
TR - Turchia 21
MA - Marocco 20
ZA - Sudafrica 20
UA - Ucraina 19
IE - Irlanda 17
JP - Giappone 17
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
VE - Venezuela 12
CL - Cile 11
EG - Egitto 11
IR - Iran 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
JO - Giordania 10
TN - Tunisia 10
BE - Belgio 9
CR - Costa Rica 9
KE - Kenya 9
UZ - Uzbekistan 8
AU - Australia 7
AZ - Azerbaigian 7
PE - Perù 7
PH - Filippine 7
KW - Kuwait 6
JM - Giamaica 5
OM - Oman 5
DZ - Algeria 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
LB - Libano 4
LT - Lituania 4
PS - Palestinian Territory 4
TH - Thailandia 4
AL - Albania 3
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
NG - Nigeria 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DK - Danimarca 2
GR - Grecia 2
KG - Kirghizistan 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
GE - Georgia 1
GM - Gambi 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
Totale 11.316
Città #
Singapore 801
San Jose 664
Dallas 612
Ashburn 510
Santa Clara 299
Ho Chi Minh City 250
Columbus 228
Seoul 214
Council Bluffs 213
Moscow 189
Hanoi 179
Trento 167
Riga 147
Lauterbourg 127
Los Angeles 127
The Dalles 113
Hefei 107
New York 107
Hong Kong 101
Milan 97
São Paulo 86
Boardman 73
Beijing 68
Buffalo 67
Jakarta 66
Helsinki 65
Chicago 53
Rome 50
Toenisvorst 49
Redondo Beach 46
Munich 43
St Louis 40
Orem 34
Lappeenranta 33
Warsaw 33
Uhlingen-Birkendorf 31
Amsterdam 29
Da Nang 29
Denver 29
Cavalese 25
Miano 24
Haiphong 23
Nuremberg 22
Montreal 21
Rio de Janeiro 21
Salt Lake City 21
Bari 20
Boston 20
Chennai 20
Civezzano 19
Guangzhou 19
London 18
Baghdad 17
Brooklyn 17
Mexico City 17
Biên Hòa 16
Lavis 16
Mumbai 16
Phoenix 16
Curitiba 15
Dublin 15
Frankfurt am Main 15
Johannesburg 15
Salvador 15
Stockholm 15
Toronto 15
Atlanta 14
Turku 14
Brasília 13
Indianapolis 13
Manchester 13
Naples 13
Fortaleza 12
Shenzhen 12
Bassano del Grappa 11
Belo Horizonte 11
Amman 10
Dhaka 10
Ninh Bình 10
Vienna 10
Ankara 9
Bologna 9
Can Tho 9
Guayaquil 9
Mattarello 9
Nairobi 9
Tampa 9
Tokyo 9
Turin 9
Xi'an 9
Barnet 8
Bến Tre 8
Charlotte 8
Elk Grove Village 8
Genoa 8
Houston 8
Joinville 8
New Delhi 8
Poplar 8
Querétaro 8
Totale 7.005
Nome #
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 265
Can nutraceuticals counteract the detrimental effects of the environment on male fertility? A parallel systematic review and expert opinion 201
Lupus vasculitis: An overview 151
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 137
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment 132
AMYLOID HEART INVOLVEMENT LEAD A FAST FATAL EVOLUTION IN A HEALTHY WOMAN: A CASE REPORT 125
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 125
Adipose failure through adipocyte overload and autoimmunity 121
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies 115
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 112
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 108
Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study 108
Direct oral anticoagulants in deep vein thrombosis associated with inferior vena cava agenesis: A report of three cases and a systematic review 107
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 105
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche 105
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis 103
A spatial view of the CD8(+) T-cell response: the case of HCV 101
Endothelial cells in tumor microenvironment: insights and perspectives 99
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 98
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 94
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population 93
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 93
When something goes wrong: B cell responses to hepatitis C virus 91
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 91
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 90
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 90
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 87
Idiopathic nonhistaminergic angioedema: A single-center real-life experience from Italy 85
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 85
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 85
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 85
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 85
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 84
Actors on the Scene: Immune Cells in the Myeloma Niche 84
Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy 83
An atypical presentation of intestinal neuroendocrine tumor 81
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 81
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 81
The influence of H. pylori infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathway 80
Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes 78
Metabolic-associated enthesitis: a review on pathophysiology, clinical relevance, diagnostic challenges, and perspective on target treatments 77
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 77
CT pulmonary angiography appropriateness in a single emergency department: does the use of revised Geneva score matter? 77
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 77
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 76
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 76
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 76
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 76
Common Variable Immunodeficiency and Gastric Malignancies 75
Non-Classical HLA Class 1b and Hepatocellular Carcinoma 75
VASCULITI NON ATEROSCLEROTICHE DI INTERESSE CHIRURGICO 75
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department 74
Age-related differences in human palatine tonsillar B cell subsets and immunoglobulin isotypes 74
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 73
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 73
Programmed death-1 (PD-1)-dependent functional impairment of CD4 + T cells in recurrent genital papilloma 72
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 72
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 72
Mucine-1 is related to cell-mediated immunoexpression and blood pressure in pulmonary artery in pulmonary arterial hypertension (PAH): Preliminary results 72
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 71
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 70
Prognostic role of neoplastic markers in Takotsubo syndrome 70
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments 70
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 69
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases 69
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 69
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 69
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 68
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules 68
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 68
The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters 68
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 68
Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT 67
Application of average volume assured pressure support (AVAPS) and ultrasound assessment in COVID-19 infection: real-life observation 67
Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma 67
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 66
Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion 64
Pancreatic cancer signaling pathways, genetic alterations, and tumor microenvironment: The barriers affecting the method of treatment 63
Apocynin regulates cytokine production of CD8+ T cells 63
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 63
Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 63
Peculiar presentation of skin lymphoma could be missdiagnosed as sarcoidosis: a case report 63
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 62
Classic pyoderma gangrenosum 62
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 62
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 61
Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting 61
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 60
INTERACTION OF JUNCTIONAL ADHESION MOLECULES IN THE BONE MARROW-NICHE: MICE MODEL AND CLINICAL IMPACT FOR MULTIPLE MYELOMA PATIENTS 59
Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report 59
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review) 59
Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis 59
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis 58
PROSTETIC AMICROBIAL ENDOCARDITIS REVEALED HEART INVOLVEMENT IN SYSTEMIC LUPUS ERITHEMATOSUS (SLE): A CASE REPORT 58
Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea 58
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients 57
Early administration of tofacitinib in COVID ‐19 pneumonitis: An open randomised controlled trial 57
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 57
From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past 57
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance 56
Totale 8.248
Categoria #
all - tutte 49.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 853
Totale 50.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241.029 0 167 89 211 9 42 136 85 58 58 70 104
2024/20252.701 40 81 135 459 124 321 95 97 265 384 281 419
2025/20268.102 322 284 1.321 1.432 703 496 1.165 211 622 728 358 460
Totale 11.832